References
Hansen, D. K., George, N. I., White, G. E., Abdel-Rahman, A., Pellicore, L. S., & Fabricant, D. (2013). Cardiotoxicity of Citrus aurantium in exercised rats. Cardiovascular Toxicity,. doi:10.1007/s12012-013-9199-x12pages.
Stohs, S. J. (2010). A review and assessment of the FDA adverse events reports and clinical case reports associated with bitter orange (Citrus aurantium) between April 2004 and October 2009. Journal of Functional Foods, 2, 235–238.
Stohs, S. J., & Preuss, H. G. (2011). The safety of bitter orange (Citrus aurantium) and p-synephrine. HerbalGram, 89, 34–39.
Stohs, S. J., Preuss, H. G., & Shara, M. (2011). The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine. Phytotherapy Research, 25, 1421–1428.
Stohs, S.J, Shara, M. (2012). A review of the safety and efficacy of Citrus aurantium in weight management. In: Obesity: Epidemiology, Pathophysiology and Prevention, 2nd Ed. D. Bagchi and H. Preuss, Ed. CRC Press. pp. 535-554.
Stohs, S. J., Preuss, H. G., & Shara, M. (2012). A review of the human clinical studies of bitter orange (Citrus aurantium) and its primary protoalkaloid p-synephrine. International Journal of Medical Sciences, 9, 527–538.
Dragull, K., Breksa, A. P., & Cain, B. (2008). Synephrine content of juice from Satsuma mandarins (Citrus unshiu Marcovitch). Journal of Agricultural and Food Chemistry, 56, 8874–8878.
Uckoo, R. M., Jayaprakasha, G. K., Nelson, D. S., & Patil, B. S. (2010). Rapid simultaneous determinations of amines and organic acids in citrus using high-performance liquid chromatography. Talanta, 83, 948–954.
Kaats, G. R., Miller, H., Preuss, H. G., & Stohs, S. J. (2013). A 60 day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract. Food and Chemical Toxicology, 55, 358–362.
Stohs, S. J., Preuss, H. G., Keith, S. C., Keith, P. L., Miller, H., & Kaats, G. R. (2011). Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes. International Journal of Medical Sciences, 8, 295–301.
Seifert, J. G., Nelson, A., Devonish, J., Burke, E. R., & Stohs, S. J. (2011). Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans. International Journal of Medical Sciences, 8, 192–197.
Stohs, S. J., Preuss, H. G., & Shara, M. (2011). A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects. Oxidative Medicine and Cellular Longevity,. doi:10.1155/2011/4829739pages.
Marles R. (2011). Synephrine, Octopamine and Caffeine health risk assessment (HRA) Report. health Canada natural health products directorate, File No. 172091, pp.1-49. http://www.nutratechinc.com/advz/advz.php?p=2.
Lynch B. (2013). Review of the safety data available on p-synephrine, caffeine and p-synephrine-caffeine containing combination products. Intertek-Cantox Report. February 19, pp. 1-20. http://nutratechinc.com/advz/UploadedFiles/2013/IntertekCantox.pdf.
Conflict of interest
The author has served as a consultant for Nutratech Inc., West Caldwell, NJ, a supplier of Citrus aurantium (bitter orange) extracts.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stohs, S.J. Questionable Conclusions in the Article “Cardiovascular Toxicity of Citrus aurantium in Exercised Rats”. Cardiovasc Toxicol 13, 180–181 (2013). https://doi.org/10.1007/s12012-013-9210-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-013-9210-6